Healthcare Equipment and Supplies
Company Overview of Creganna-Tactx Medical
Creganna-Tactx Medical provides outsourced design and manufacturing services to the medical device industry. The company specializes in minimally invasive delivery and access devices for a range of therapies. It offers a range of products in minimally invasive catheter market segments, including PTCA, PTA, neurovascular, and structural heart, as well as specialty and niche catheters, such as atherectomy, CTO, vulnerable plaque, and thrombectomy and GI catheters. The company also provides design and development services for a portfolio of projects, including PTCA and PTA balloon catheters, stent delivery systems, CTO catheters, vulnerable plaque detection catheters, embolic filter device deli...
Galway, H91 VN2T
Founded in 1979
Key Executives for Creganna-Tactx Medical
Co-Founder and Non-Executive Director
Chief Financial Officer and Director
Head of Meridian Technology Development Program
Compensation as of Fiscal Year 2016.
Creganna-Tactx Medical Key Developments
TE Connectivity Ltd., Creganna-Tactx Medical - M&A Call
Feb 2 16
To discuss the definitive agreement to acquire the Creganna Medical group for USD 895 million in an all cash transaction
Permira Reportedly Seeks To Sell Creganna
Feb 1 16
Permira Advisers Ltd. is exploring the sale of Creganna-Tactx Medical in a deal that could fetch €600 million to €1 billion, according to people with knowledge of the matter. The sale has attracted interest from companies in Creganna’s industry as well as other buyout firms, the people said, asking not to be identified because the deliberations are private. Piper Jaffray is advising Permira on the sale process, they said. A representative for Permira declined to comment. A spokesman for Piper Jaffray had no immediate comment.
Similar Private Companies By Industry
Recent Private Companies Transactions
February 2, 2016
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries